Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients

June 27, 2017 updated by: Navid Ardjomand, Medical University of Graz

Optical Quality After Implantation of a Spherical or Aspherical Intraocular Lens in Hypermetropic Patients: A Randomized Clinical Trial

The purpose of this study is to evaluate differences in the depth of focus after implantation of a spherical or aspheric IOL in hypermetropic and emmetropic patients. After implantation of a spherical IOL hypermetropic patients may achieve a better depth of focus compared to emmetropic patients due to a larger amount of spherical aberrations.

Study Overview

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Graz, Austria, 8036
        • Dept. of Ophthalmology, Medical University of Graz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

38 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cataract
  • Dioptric power of IOL >22.0 D in hypermetropic patients and 18.0-22.0 D in emmetropic patients, respectively

Exclusion Criteria:

  • Uveitis, pathology of the retina or the optic nerve
  • Corneal scarring or irregularities
  • Astigmatism >1.5 D
  • Amblyopia
  • Perioperative complications
  • Postoperative refractive error >2.0 D of spherical equivalent
  • Postoperative DCVA <0.8 (ETDRS)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypermetropic, spherical IOL
AMO Sensar AR40e
Experimental: Hypermetropic, aspheric IOL
AMO Tecnis ZA9003
Active Comparator: Emmetropic, spherical IOL
AMO Sensar AR40e
Active Comparator: Emmetropic, aspheric IOL
AMO Tecnis ZA9003

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Distance-corrected intermediate visual acuity
Time Frame: 3 month postop
3 month postop

Secondary Outcome Measures

Outcome Measure
Time Frame
Distance-corrected near visual acuity
Time Frame: 3 month postop
3 month postop
Uncorrected distance visual acuity
Time Frame: 3 month postop
3 month postop
Corrected distance visual acuity
Time Frame: 3 month postop
3 month postop
Uncorrected near visual acuity
Time Frame: 3 month postop
3 month postop
Corrected near visual acuity
Time Frame: 3 month postop
3 month postop
Pseudoaccomodation
Time Frame: 3 month postop
3 month postop
Photopic contrast sensitivity
Time Frame: 3 month postop
3 month postop
Mesopic contrast sensitivity
Time Frame: 3 month postop
3 month postop
Spherical aberrations
Time Frame: 3 month postop
3 month postop
High order aberrations
Time Frame: 3 month postop
3 month postop

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Navid Ardjomand, MD, Dept. of Ophthalmology, Medical University of Graz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

June 26, 2016

Study Registration Dates

First Submitted

November 21, 2013

First Submitted That Met QC Criteria

November 21, 2013

First Posted (Estimate)

November 26, 2013

Study Record Updates

Last Update Posted (Actual)

June 28, 2017

Last Update Submitted That Met QC Criteria

June 27, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SIOLvsAIOL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on AMO Sensar AR40e

3
Subscribe